%0 Journal Article %A Chen, Shuling %A Peng, Zhenwei %A Wei, Mengchao %A Liu, Weifeng %A Dai, Zihao %A Wang, Haibo %A Mei, Jie %A Cheong, Mingfong %A Zhang, Hanmei %A Kuang, Ming %D 2018 %T Additional file 8: of Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis %U https://springernature.figshare.com/articles/journal_contribution/Additional_file_8_of_Sorafenib_versus_Transarterial_chemoembolization_for_advanced-stage_hepatocellular_carcinoma_a_cost-effectiveness_analysis/6105344 %R 10.6084/m9.figshare.6105344.v1 %2 https://springernature.figshare.com/ndownloader/files/10999073 %K Sorafenib %K Transarterial chemoembolization %K Advanced-stage hepatocellular carcinoma %K Cost-effectiveness analysis %K Markov model %X Table S7. References used to derive monthly mortality of patients with compensated cirrhosis and progressive HCC after TACE. (DOCX 13 kb) %I figshare